Skip to content

The clinical study of cerebral functional remodeling in patients with traumatic amputation

The clinical study of cerebral functional remodeling in patients with traumatic amputation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011413
Enrollment
Unknown
Registered
2017-05-16
Start date
2017-05-01
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic amputation

Interventions

Test Group:Install prostheses and carry out rehabilitation training at one month after amputation
Positive control group:Install prostheses and carry out rehabilitation training at three months after amputation

Sponsors

Shanghai Jiaotong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18 to 50 years patient with upper limb limb defect by trauma; 2) amputation of upper limb limb has been completed, physical examination and history show healthy and stable, to be able to participate in the study and follow-up; 3) did not participate in other clinical trials in past 3 months; 4) Patients are voluntarily involved in this clinical trial and signed informed consent

Exclusion criteria

Exclusion criteria: 1) non-traumatic patients with upper limb limb defects or congenital upper limb limb defects; 2) acute and chronic local or systemic infection or sepsis, amputation or other parts of the body there are active infection lesions; 3) patients with limb length less than the diameter of the upper limb amputation; 4) history of brain trauma, stroke history patients, patients with epilepsy and other patients with other diseases affecting brain function; 5) mental illness patients or patients are mentally incapable or unable to understand the requirements of participation in research; 6) subjects were immunosuppressed, with autoimmune diseases or immunosuppressive disorders; 7) long-term alcohol abuse, drug abuse and other patients; 8) Pregnant patients; 9) to merge other diseases and critically ill, life expectancy of less than one year, it is difficult to test the effectiveness and safety of the exact evaluation of those who; 10) Researchers consider whose who not eligible for inclusion.

Design outcomes

Primary

MeasureTime frame
Brain functional remodeling occurs abnormally or not;

Secondary

MeasureTime frame
SF-36 Quality of Life score;Trinity amputation and prosthetic experience scale (TAPES);

Countries

China

Contacts

Public ContactXianyou Zheng

Shanghai Jiaotong University Affiliated Sixth People's Hospital

zhengxianyou@126.com+86 13916180968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026